Hosted on MSN6h
GeneDx launches ultrarapid whole genome sequencing for critically ill infants
The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
GeneDx speeds up genome sequencing for NICU care
GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...
GeneDx CEO wants genetic testing for every newborn
GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference
GeneDx (Nasdaq: WGS), today announced that company management will participate in the TD Cowen Health Care Conference from ...
GeneDX Holdings Q4 2024 Earnings Preview
GeneDX Holdings reports Q4 earnings on February 18th. Find out why WGS stock is a strong play in the booming genetics testing ...
The Gazette5d
GeneDx CEO wants genetic testing for every newborn
GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the testing common at birth. The goal: Identify potential diseases or conditions ...